Aspirin 100 mg

DRUG4 trials

Conditions

Acute Coronary Syndromes (ACS)Chronic Obstructive Pulmonary DiseaseCoronary Artery DiseaseCoronary Artery EctasiaHigh-Normal Blood PressureHyperuricemiaMild Essential HypertensionNSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)

Phase 2

ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts

CompletedNCT02519608

University Hospital of FerraraChronic Obstructive Pulmonary Disease, Coronary Artery Disease

Start: 2015-09-30End: 2017-01-31Updated: 2018-05-02

Phase 4

Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension

TerminatedNCT00449618

University of VigoHigh-Normal Blood Pressure, Mild Essential Hypertension

Start: 2007-01-31End: 2008-12-31Updated: 2009-01-05

Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia

RecruitingNCT07511257

Instituto Nacional de Cardiologia Ignacio ChavezAcute Coronary Syndromes (ACS), Coronary Artery Ectasia, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI) +1

Start: 2026-02-11End: 2029-06-01Target: 326Updated: 2026-04-09

Unknown Phase

The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Disease（AURORA）

NCT03691688

Shanghai Zhongshan HospitalCoronary Artery Disease, Hyperuricemia

Start: 2018-12-01End: 2022-03-01Target: 2000Updated: 2018-11-29

Echocardiography2021-05-109 citations

Ticagrelor Improves Endothelial Function by Decreasing Circulating Epidermal Growth Factor (EGF)

Frontiers in Physiology2018-04-0631 citations

Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease

Thrombosis and Haemostasis2017-03-2357 citations

Aspirin 100 mg

Sponsors

Conditions

Phase 2

Phase 4

Unknown Phase

Related Papers